OSMITROL 5% IN WATER IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Osmitrol 5% In Water In Plastic Container, and when can generic versions of Osmitrol 5% In Water In Plastic Container launch?
Osmitrol 5% In Water In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.
The generic ingredient in OSMITROL 5% IN WATER IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the mannitol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for OSMITROL 5% IN WATER IN PLASTIC CONTAINER?
- What are the global sales for OSMITROL 5% IN WATER IN PLASTIC CONTAINER?
- What is Average Wholesale Price for OSMITROL 5% IN WATER IN PLASTIC CONTAINER?
Summary for OSMITROL 5% IN WATER IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 6 |
| DailyMed Link: | OSMITROL 5% IN WATER IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Linear Clinical Research | Phase 1 |
| CPR Pharma Services Pty Ltd, Australia | Phase 1 |
| Celtaxsys, Inc. | Phase 1 |
See all OSMITROL 5% IN WATER IN PLASTIC CONTAINER clinical trials
Pharmacology for OSMITROL 5% IN WATER IN PLASTIC CONTAINER
| Drug Class | Osmotic Diuretic |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for OSMITROL 5% IN WATER IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baxter Hlthcare | OSMITROL 5% IN WATER IN PLASTIC CONTAINER | mannitol | INJECTABLE;INJECTION | 013684-005 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for OSMITROL 5% IN WATER IN PLASTIC CONTAINER
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Pharmaxis Europe Limited | Bronchitol | mannitol | EMEA/H/C/001252 Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care. |
Authorised | no | no | no | 2012-04-13 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
